Systemic scleroderma (SSc), also known as systemic sclerosis, is a rare autoimmune disorder characterized by fibrosis of the skin and internal organs, as well as vascular abnormalities. Atherosclerosis, the accumulation of lipids and fibrous tissue in arterial walls, is a significant cause of cardiovascular morbidity and mortality. Patients with systemic scleroderma are at an elevated risk for developing atherosclerosis, with vascular damage playing a central role in its pathogenesis. This article reviews the multifactorial risk factors contributing to the development of atherosclerosis in patients with systemic scleroderma, focusing on endothelial dysfunction, chronic inflammation, dyslipidemia, and other clinical factors. The goal of this article is to enhance the understanding of cardiovascular risk in this population and emphasize the importance of early diagnosis and targeted interventions.

Systemic scleroderma, atherosclerosis, cardiovascular diseases

Bairkdar M., Rossides M., Westerlind H., Hesselstrand R., Arkema E.V., Holmqvist M. Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and metaanalysis // Rheumatology (Oxford, England). - 2021. - №60. – P.3121–3133.

Brown M., O’Reilly S. The immunopathogenesis of fibrosis in systemic sclerosis // Clinical and Experimental Immunology. - 2019. - №195.- P.310–321.

Cassius C., Seta V., Monfort J.B., Baudot N.A., Rivière S., Mekinian A., et al. Systemic sclerosis is associated with lower limb vascular stiffness and microvascular impairment: results from a prospective study. // Clinical Rheumatology. - 2021;- №40. – P.3679–3686.

Ganiyeva N.A., Rizamukhamedova M.Z., Nabiyeva D.A., Aripova N.A. Clinic - diagnostic aspects of modern biomarkers of early atherosclerosis and fibrotic activity of systemic scleroderma // Asian Journal of Medical Principles and Clinical Practice. - 2021.- №4(3). - P.1-13.

Gigante A., Navarini L., Margiotta D., Amoroso A., Barbano B., Cianci R., et al. Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy // Microvascular Research. – 2017. - №114. – P. 41–45

Hesselvig J.H., Kofoed K., Wu J.J., Dreyer L., Gislason G., Ahlehoff O. Localized Scleroderma, Systemic Sclerosis and Cardiovascular Risk: A Danish Nationwide Cohort Study // Acta Dermatovenereologica. – 2018. – №98. – P.361–365.

Kuley R., Stultz R.D., Duvvuri B., Wang T., Fritzler M.J., Hesselstrand R., et al. N-Formyl Methionine Peptide-Mediated Neutrophil Activation in Systemic Sclerosis // Frontiers in Immunology. – 2022. - №12. – P.785275.

Magda S.L., Mincu R.I., Mihai C.M., Cinteza M., Vinereanu D. Atherosclerosis in Systemic Sclerosis: a Modern Controversy // Maedica (Bucur). - 2015 Sep. - №10(3). – P.248-256.

Nihtyanova S.I., Denton C.P. Pathogenesis of systemic sclerosis associated interstitial lung disease // Journal of Scleroderma and Related Disorders. -2020. -№5. – P.6–16.

Poznyak A.V., Bharadwaj D., Prasad G., Grechko A.V., Sazonova M.A., Orekhov A.N. Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD // International Journal of Molecular Sciences. - 2021. - №22. – P.6702.

Yoshizaki A., Fukasawa T., Ebata S., Yoshizaki-Ogawa A., Sato S. Involvement of B cells in the development of systemic sclerosis // Frontiers in Immunology. – 2022. - №13. – P.938785.

Zhu Y., Xian X., Wang Z., Bi Y., Chen Q., Han X., et al. Research Progress on the Relationship between Atherosclerosis and Inflammation // Biomolecules. – 2018.- №8. – P.80.